Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Debottlenecking R&D with Automated Powder Dispensing

The Enabling Technologies Consortium™ (ETC) - group of major pharmaceutical and biotechnology companies  - has published a new study on powder dispensing with the aim of easing R&D bottlenecks, particularly in high-throughput experimentation.

In an effort to understand the relative merits and disadvantages of existing automated powder dispensing technologies, an independent evaluation was carried out by the ETC's High Throughput Experimentation (HTE) working group. This working group comprised of AstraZeneca (AZ), Bristol-Myers Squibb (BMS), GlaxoSmithKline (GSK), Merck & Co., and Pfizer. The study evaluated four commercially available automated powder dispensing platforms, including Quantos from METTLER TOLEDO, to assess their abilities to accurately weigh a wide range of different powder types into vials.

The results of this benchmarking study, entitled "Collaborative Evaluation of Commercially Available Automated Powder Dispensing Platforms for High Throughput Experimentation in Pharmaceutical Applications", were presented at Pittcon 2018 [1] and will be published in OPRD [2].

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!

Login
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register